Loading…
Safety of Immunization for Children with Immune Thrombocytopenia
Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thrombocytopenia, and evaluate the safety of immunization...
Saved in:
Published in: | Vaccines (Basel) 2024-01, Vol.12 (1), p.66 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c511t-c9a6555ed6dc170177a528e71a7c8e06a8ede7135d432ac310e3f15e0893f9e93 |
container_end_page | |
container_issue | 1 |
container_start_page | 66 |
container_title | Vaccines (Basel) |
container_volume | 12 |
creator | Wang, Xiangshi Feng, Tianxing Wang, Chuning Li, Jingjing Ge, Yanling Zhai, Xiaowen Wang, Hongsheng Zeng, Mei |
description | Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thrombocytopenia, and evaluate the safety of immunization after ITP remission. We included 186 children with an ITP history and followed up with them for two years after receiving re-immunization recommendations. The participants had an overall age-appropriate vaccine coverage of 57.9%. Vaccine-associated thrombocytopenia occurred in 99 (53.2%, 95% CI = 46.06-60.26) children ranging from 0 to 34 days following immunization, with 14 vaccines involved. One hundred and fifty-four (82.3%, 95% CI = 76.72-87.54) children were advised to restart immunization, whereas 32 (17.2%, 95% CI = 12.46-23.28) were advised to postpone partial or full vaccination. Following the follow-up, 150 (80.6%, 95% CI = 74.37-85.68) children completed the catch-up immunization, whereas 27 (14.5%, 95% CI = 10.17-20.30) partially completed it. Four patients with thrombocytopenia relapsed following the re-immunization. Incomplete catch-up immunization was related to the factors of chronic thrombocytopenia, vaccine-associated thrombocytopenia, and the relapse of ITP following re-immunization. ITP may occur after immunization with vaccines other than measles-containing vaccines. Re-immunization in children with ITP generally does not result in a relapse, regardless of whether the previous thrombocytopenia was vaccine-associated. |
doi_str_mv | 10.3390/vaccines12010066 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e3b4a4eb4679477893e02efbfb9782d9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A780928361</galeid><doaj_id>oai_doaj_org_article_e3b4a4eb4679477893e02efbfb9782d9</doaj_id><sourcerecordid>A780928361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-c9a6555ed6dc170177a528e71a7c8e06a8ede7135d432ac310e3f15e0893f9e93</originalsourceid><addsrcrecordid>eNptkk1vEzEQhlcIRKvSOye0EhcuKWM7_jpBFfERqRIHisTN8nrHiaNdO3h3W4Vfj0NKlVTYB9sz7_tYHk9VvSZwxZiG93fWuRBxIBQIgBDPqnMKUsyYZj-fH-3Pqsth2EAZmjAl5MvqjCnKQUl9Xn38bj2Ouzr5etn3Uwy_7RhSrH3K9WIdujZjrO_DuD6ksb5d59Q3ye3GtMUY7KvqhbfdgJcP60X14_On28XX2c23L8vF9c3McULGmdNWcM6xFa0jEoiUllOFkljpFIKwCttyYrydM2odI4DME46gNPMaNbuolgdum-zGbHPobd6ZZIP5G0h5ZWweg-vQIGvmdo7NXEg9l7IQECj6xjdaKtruWR8OrO3U9Ng6jGO23Qn0NBPD2qzSnSGgKAhCC-HdAyGnXxMOo-nD4LDrbMQ0DYZqIjkXlPMifftEuklTjqVWe1X5BA36SLWy5QUh-lQudnuouZYKNFVMkKK6-o-qzBb74FJEH0r8xAAHg8tpGDL6x0cSMPsuMk-7qFjeHBfn0fCvZ9gfFYTCvQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918799095</pqid></control><display><type>article</type><title>Safety of Immunization for Children with Immune Thrombocytopenia</title><source>Publicly Available Content Database</source><source>PubMed Central (PMC)</source><creator>Wang, Xiangshi ; Feng, Tianxing ; Wang, Chuning ; Li, Jingjing ; Ge, Yanling ; Zhai, Xiaowen ; Wang, Hongsheng ; Zeng, Mei</creator><creatorcontrib>Wang, Xiangshi ; Feng, Tianxing ; Wang, Chuning ; Li, Jingjing ; Ge, Yanling ; Zhai, Xiaowen ; Wang, Hongsheng ; Zeng, Mei</creatorcontrib><description>Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thrombocytopenia, and evaluate the safety of immunization after ITP remission. We included 186 children with an ITP history and followed up with them for two years after receiving re-immunization recommendations. The participants had an overall age-appropriate vaccine coverage of 57.9%. Vaccine-associated thrombocytopenia occurred in 99 (53.2%, 95% CI = 46.06-60.26) children ranging from 0 to 34 days following immunization, with 14 vaccines involved. One hundred and fifty-four (82.3%, 95% CI = 76.72-87.54) children were advised to restart immunization, whereas 32 (17.2%, 95% CI = 12.46-23.28) were advised to postpone partial or full vaccination. Following the follow-up, 150 (80.6%, 95% CI = 74.37-85.68) children completed the catch-up immunization, whereas 27 (14.5%, 95% CI = 10.17-20.30) partially completed it. Four patients with thrombocytopenia relapsed following the re-immunization. Incomplete catch-up immunization was related to the factors of chronic thrombocytopenia, vaccine-associated thrombocytopenia, and the relapse of ITP following re-immunization. ITP may occur after immunization with vaccines other than measles-containing vaccines. Re-immunization in children with ITP generally does not result in a relapse, regardless of whether the previous thrombocytopenia was vaccine-associated.</description><identifier>ISSN: 2076-393X</identifier><identifier>EISSN: 2076-393X</identifier><identifier>DOI: 10.3390/vaccines12010066</identifier><identifier>PMID: 38250879</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Antigens ; catch-up immunization ; Chicken pox ; Children ; Diphtheria ; Drug dosages ; Handbooks ; Health aspects ; Hepatitis ; Idiopathic thrombocytopenic purpura ; immune thrombocytopenia ; Immunization ; Management ; Measles ; Mumps ; Parents & parenting ; Pediatrics ; Poliomyelitis ; Prevention ; Remission ; Remission (Medicine) ; Rubella ; Safety ; Steroids ; Surveillance ; Tetanus ; Thrombocytopenia ; vaccine hesitancy ; vaccine-associated thrombocytopenia ; Vaccines ; Whooping cough</subject><ispartof>Vaccines (Basel), 2024-01, Vol.12 (1), p.66</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c511t-c9a6555ed6dc170177a528e71a7c8e06a8ede7135d432ac310e3f15e0893f9e93</cites><orcidid>0000-0003-1479-6022</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2918799095/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918799095?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38250879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xiangshi</creatorcontrib><creatorcontrib>Feng, Tianxing</creatorcontrib><creatorcontrib>Wang, Chuning</creatorcontrib><creatorcontrib>Li, Jingjing</creatorcontrib><creatorcontrib>Ge, Yanling</creatorcontrib><creatorcontrib>Zhai, Xiaowen</creatorcontrib><creatorcontrib>Wang, Hongsheng</creatorcontrib><creatorcontrib>Zeng, Mei</creatorcontrib><title>Safety of Immunization for Children with Immune Thrombocytopenia</title><title>Vaccines (Basel)</title><addtitle>Vaccines (Basel)</addtitle><description>Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thrombocytopenia, and evaluate the safety of immunization after ITP remission. We included 186 children with an ITP history and followed up with them for two years after receiving re-immunization recommendations. The participants had an overall age-appropriate vaccine coverage of 57.9%. Vaccine-associated thrombocytopenia occurred in 99 (53.2%, 95% CI = 46.06-60.26) children ranging from 0 to 34 days following immunization, with 14 vaccines involved. One hundred and fifty-four (82.3%, 95% CI = 76.72-87.54) children were advised to restart immunization, whereas 32 (17.2%, 95% CI = 12.46-23.28) were advised to postpone partial or full vaccination. Following the follow-up, 150 (80.6%, 95% CI = 74.37-85.68) children completed the catch-up immunization, whereas 27 (14.5%, 95% CI = 10.17-20.30) partially completed it. Four patients with thrombocytopenia relapsed following the re-immunization. Incomplete catch-up immunization was related to the factors of chronic thrombocytopenia, vaccine-associated thrombocytopenia, and the relapse of ITP following re-immunization. ITP may occur after immunization with vaccines other than measles-containing vaccines. Re-immunization in children with ITP generally does not result in a relapse, regardless of whether the previous thrombocytopenia was vaccine-associated.</description><subject>Age</subject><subject>Antigens</subject><subject>catch-up immunization</subject><subject>Chicken pox</subject><subject>Children</subject><subject>Diphtheria</subject><subject>Drug dosages</subject><subject>Handbooks</subject><subject>Health aspects</subject><subject>Hepatitis</subject><subject>Idiopathic thrombocytopenic purpura</subject><subject>immune thrombocytopenia</subject><subject>Immunization</subject><subject>Management</subject><subject>Measles</subject><subject>Mumps</subject><subject>Parents & parenting</subject><subject>Pediatrics</subject><subject>Poliomyelitis</subject><subject>Prevention</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Rubella</subject><subject>Safety</subject><subject>Steroids</subject><subject>Surveillance</subject><subject>Tetanus</subject><subject>Thrombocytopenia</subject><subject>vaccine hesitancy</subject><subject>vaccine-associated thrombocytopenia</subject><subject>Vaccines</subject><subject>Whooping cough</subject><issn>2076-393X</issn><issn>2076-393X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vEzEQhlcIRKvSOye0EhcuKWM7_jpBFfERqRIHisTN8nrHiaNdO3h3W4Vfj0NKlVTYB9sz7_tYHk9VvSZwxZiG93fWuRBxIBQIgBDPqnMKUsyYZj-fH-3Pqsth2EAZmjAl5MvqjCnKQUl9Xn38bj2Ouzr5etn3Uwy_7RhSrH3K9WIdujZjrO_DuD6ksb5d59Q3ye3GtMUY7KvqhbfdgJcP60X14_On28XX2c23L8vF9c3McULGmdNWcM6xFa0jEoiUllOFkljpFIKwCttyYrydM2odI4DME46gNPMaNbuolgdum-zGbHPobd6ZZIP5G0h5ZWweg-vQIGvmdo7NXEg9l7IQECj6xjdaKtruWR8OrO3U9Ng6jGO23Qn0NBPD2qzSnSGgKAhCC-HdAyGnXxMOo-nD4LDrbMQ0DYZqIjkXlPMifftEuklTjqVWe1X5BA36SLWy5QUh-lQudnuouZYKNFVMkKK6-o-qzBb74FJEH0r8xAAHg8tpGDL6x0cSMPsuMk-7qFjeHBfn0fCvZ9gfFYTCvQ</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Wang, Xiangshi</creator><creator>Feng, Tianxing</creator><creator>Wang, Chuning</creator><creator>Li, Jingjing</creator><creator>Ge, Yanling</creator><creator>Zhai, Xiaowen</creator><creator>Wang, Hongsheng</creator><creator>Zeng, Mei</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1479-6022</orcidid></search><sort><creationdate>20240101</creationdate><title>Safety of Immunization for Children with Immune Thrombocytopenia</title><author>Wang, Xiangshi ; Feng, Tianxing ; Wang, Chuning ; Li, Jingjing ; Ge, Yanling ; Zhai, Xiaowen ; Wang, Hongsheng ; Zeng, Mei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-c9a6555ed6dc170177a528e71a7c8e06a8ede7135d432ac310e3f15e0893f9e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Antigens</topic><topic>catch-up immunization</topic><topic>Chicken pox</topic><topic>Children</topic><topic>Diphtheria</topic><topic>Drug dosages</topic><topic>Handbooks</topic><topic>Health aspects</topic><topic>Hepatitis</topic><topic>Idiopathic thrombocytopenic purpura</topic><topic>immune thrombocytopenia</topic><topic>Immunization</topic><topic>Management</topic><topic>Measles</topic><topic>Mumps</topic><topic>Parents & parenting</topic><topic>Pediatrics</topic><topic>Poliomyelitis</topic><topic>Prevention</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Rubella</topic><topic>Safety</topic><topic>Steroids</topic><topic>Surveillance</topic><topic>Tetanus</topic><topic>Thrombocytopenia</topic><topic>vaccine hesitancy</topic><topic>vaccine-associated thrombocytopenia</topic><topic>Vaccines</topic><topic>Whooping cough</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xiangshi</creatorcontrib><creatorcontrib>Feng, Tianxing</creatorcontrib><creatorcontrib>Wang, Chuning</creatorcontrib><creatorcontrib>Li, Jingjing</creatorcontrib><creatorcontrib>Ge, Yanling</creatorcontrib><creatorcontrib>Zhai, Xiaowen</creatorcontrib><creatorcontrib>Wang, Hongsheng</creatorcontrib><creatorcontrib>Zeng, Mei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest_Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vaccines (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xiangshi</au><au>Feng, Tianxing</au><au>Wang, Chuning</au><au>Li, Jingjing</au><au>Ge, Yanling</au><au>Zhai, Xiaowen</au><au>Wang, Hongsheng</au><au>Zeng, Mei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of Immunization for Children with Immune Thrombocytopenia</atitle><jtitle>Vaccines (Basel)</jtitle><addtitle>Vaccines (Basel)</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>12</volume><issue>1</issue><spage>66</spage><pages>66-</pages><issn>2076-393X</issn><eissn>2076-393X</eissn><abstract>Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thrombocytopenia, and evaluate the safety of immunization after ITP remission. We included 186 children with an ITP history and followed up with them for two years after receiving re-immunization recommendations. The participants had an overall age-appropriate vaccine coverage of 57.9%. Vaccine-associated thrombocytopenia occurred in 99 (53.2%, 95% CI = 46.06-60.26) children ranging from 0 to 34 days following immunization, with 14 vaccines involved. One hundred and fifty-four (82.3%, 95% CI = 76.72-87.54) children were advised to restart immunization, whereas 32 (17.2%, 95% CI = 12.46-23.28) were advised to postpone partial or full vaccination. Following the follow-up, 150 (80.6%, 95% CI = 74.37-85.68) children completed the catch-up immunization, whereas 27 (14.5%, 95% CI = 10.17-20.30) partially completed it. Four patients with thrombocytopenia relapsed following the re-immunization. Incomplete catch-up immunization was related to the factors of chronic thrombocytopenia, vaccine-associated thrombocytopenia, and the relapse of ITP following re-immunization. ITP may occur after immunization with vaccines other than measles-containing vaccines. Re-immunization in children with ITP generally does not result in a relapse, regardless of whether the previous thrombocytopenia was vaccine-associated.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38250879</pmid><doi>10.3390/vaccines12010066</doi><orcidid>https://orcid.org/0000-0003-1479-6022</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2076-393X |
ispartof | Vaccines (Basel), 2024-01, Vol.12 (1), p.66 |
issn | 2076-393X 2076-393X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_e3b4a4eb4679477893e02efbfb9782d9 |
source | Publicly Available Content Database; PubMed Central (PMC) |
subjects | Age Antigens catch-up immunization Chicken pox Children Diphtheria Drug dosages Handbooks Health aspects Hepatitis Idiopathic thrombocytopenic purpura immune thrombocytopenia Immunization Management Measles Mumps Parents & parenting Pediatrics Poliomyelitis Prevention Remission Remission (Medicine) Rubella Safety Steroids Surveillance Tetanus Thrombocytopenia vaccine hesitancy vaccine-associated thrombocytopenia Vaccines Whooping cough |
title | Safety of Immunization for Children with Immune Thrombocytopenia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A35%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20Immunization%20for%20Children%20with%20Immune%20Thrombocytopenia&rft.jtitle=Vaccines%20(Basel)&rft.au=Wang,%20Xiangshi&rft.date=2024-01-01&rft.volume=12&rft.issue=1&rft.spage=66&rft.pages=66-&rft.issn=2076-393X&rft.eissn=2076-393X&rft_id=info:doi/10.3390/vaccines12010066&rft_dat=%3Cgale_doaj_%3EA780928361%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-c9a6555ed6dc170177a528e71a7c8e06a8ede7135d432ac310e3f15e0893f9e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2918799095&rft_id=info:pmid/38250879&rft_galeid=A780928361&rfr_iscdi=true |